Unencrypted BLE Transmission and DoS Flaw Expose Apollo Pharmacy Glucose Monitor Users
Written by AI from the linked story. Not reviewed by an editor. How this works
The Apollo Pharmacy APG-01 BT blood glucose monitor contains two serious vulnerabilities: one allowing passive interception of sensitive health data over Bluetooth Low Energy (CVE-2026-50034), and another enabling denial-of-service by monopolizing the device's single connection slot (CVE-2026-52866). These flaws are particularly dangerous because they target a medical device that handles protected health information (PHI), meaning real patients could have their glucose readings exposed or be locked out of a life-relevant monitoring tool. The situation is compounded by Apollo Pharmacy's failure to respond to CISA's coordination requests, leaving users with no vendor-issued remediation path. This highlights the broader risk of IoT and connected medical devices entering the market without adequate security validation or post-market vulnerability response processes.
Tactical Insight
Immediate actions
- Disable Bluetooth on the APG-01 BT device when not actively in use to minimize the attack surface for nearby adversaries.
- Avoid using the device in public or high-density areas where malicious actors within BLE range could intercept transmissions.
- Contact Apollo Pharmacy directly and request a security patch or firmware update timeline, escalating to regulatory bodies (e.g., FDA, CISA) if unresponsive.
Long-term improvements
- Require BLE-enabled medical devices to implement authenticated and encrypted communication (e.g., BLE pairing with AES-128) before procurement or deployment.
- Establish a vendor security assessment process that includes mandatory incident response SLAs as a condition of supplier contracts.
- Maintain an inventory of all connected medical devices and track their CVE exposure using a vulnerability management platform.
Detection & monitoring measures
- Deploy BLE monitoring tools in clinical environments to detect unauthorized scanning or connection attempts targeting medical devices.
- Subscribe to CISA ICS-CERT advisories and automate alerting for CVEs affecting devices in your organization's medical device inventory.
- Implement network/RF anomaly detection to identify unusual Bluetooth activity patterns indicative of connection-slot exhaustion (DoS) attacks.